In a rat model of vasospasm, MLC20 phosphorylation mediates early arterial narrowing, whereas later stages are associated with loss of MLC20, suggesting alternative mechanisms for sustained vasospasm.
Answers are grounded in this paper and cite their sources.
Rat vasospasm data suggest biphasic mechanisms; hypothesis-generating for targeted human therapies, should not yet alter practice.
The phosphorylation of an M(r) 20,000 myosin light chain (MLC20) promotes the generation of contractile force through actin-myosin adenosine triphosphatase in most agonist-mediated vascular smooth muscle cell contraction. However, the role of calcium-mediated contractile processes in sustained arterial narrowing after subarachnoid hemorrhage remains unknown. In a femoral artery model of vasospasm, whole blood was applied to arteries in 54 rats for periods of 2 to 10 days; the contralateral artery treated with platelet-rich plasma served as matched control. During the early stage of vasospasm (Days 2-5), in the media of arteries exposed to blood, MLC20 phosphorylation (including diphosphorylated forms) increased significantly (30-38%; P < 0.05); total medial MLC20 during this interval was comparable to that in controls. After 5 days, however, total MLC20 decreased markedly (> 90%; P < 0.01) compared with controls; phosphorylated MLC20 was undetectable during this interval. MLC20-mediated contractile processes may be prominent in the early stages of arterial narrowing after subarachnoid hemorrhage; later stages are associated with the loss of MLC20 and the possible persistence of arterial narrowing by other mechanisms.
No takes yet. Share an insight, caveat, or question.
Harada et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: